{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:02:33Z","timestamp":1794499353876,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1053\/j.semnuclmed.2026.05.010","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:38:02Z","timestamp":1781091482000},"page":"1151-1164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The diagnostic performance and clinical value of [18F]FDG PET\/CT in pleural mesothelioma \u2013 A systematic review and meta-analysis"],"prefix":"10.1053","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2397-0961","authenticated-orcid":false,"given":"Anne H.","family":"Thostrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja U.","family":"Stubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias P.","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-0967","authenticated-orcid":false,"given":"Morten","family":"Bentestuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-8269","authenticated-orcid":false,"given":"Anne V.","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-288X","authenticated-orcid":false,"given":"Helle D.","family":"Zacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"33","author":"Popat","year":"2022","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1053\/j.semnuclmed.2026.05.010_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13195837","article-title":"Malignant pleural mesothelioma: a comprehensive review","volume":"13","author":"Jain","year":"2024","journal-title":"J Clin Med"},{"issue":"13","key":"10.1053\/j.semnuclmed.2026.05.010_bib0003","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American society of clinical oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.010_bib0004","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jtho.2022.11.018","article-title":"Considerations for imaging of malignant pleural Mesothelioma: a consensus statement from the international mesothelioma interest group","volume":"18","author":"Katz","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.010_bib0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/icvts\/ivz303","article-title":"18F-fluorodeoxyglucose positron emission tomography in malignant pleural mesothelioma: diagnostic and prognostic performance and its correlation to pathological results","volume":"30","author":"Lococo","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.05.010_bib0006","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.semnuclmed.2021.04.002","article-title":"PET\/CT variants and pitfalls in lung cancer and mesothelioma","volume":"51","author":"Lopci","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.010_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.acra.2013.09.015","article-title":"Diagnostic accuracy of 18F-FDG-PET and PET\/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis","volume":"21","author":"Treglia","year":"2014","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.010_bib0008","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"Jama"},{"key":"10.1053\/j.semnuclmed.2026.05.010_bib0009","series-title":"The Oxford Levels of Evidence 2","article-title":"OCEBM levels of evidence working group","year":"2011"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.010_bib0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2026.05.010_bib0011","doi-asserted-by":"crossref","unstructured":"Deeks JJ, et al., Cochrane handbook for systematic reviews of diagnostic test accuracy. Version 2.0. 2023.","DOI":"10.1002\/9781119756194"},{"key":"10.1053\/j.semnuclmed.2026.05.010_bib0012","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jss.2025.09.072","article-title":"Diagnostic test accuracy meta-analysis: a practical guide to hierarchical models","volume":"315","author":"Arredondo Montero","year":"2025","journal-title":"J Surg Res"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.010_bib0013","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/etm.2012.572","article-title":"Clinical utility of 18-fluorodeoxyglucose positron emission tomography\/computed tomography in malignant pleural mesothelioma","volume":"4","author":"Terada","year":"2012","journal-title":"Exp Ther Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161764","article-title":"The role of 18F-FDG PET\/CT integrated imaging in distinguishing malignant from benign pleural effusion","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.010_bib0016","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1148\/radiol.12110872","article-title":"Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging\u2013initial experience","volume":"263","author":"Coolen","year":"2012","journal-title":"Radiology"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.010_bib0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2008-1039314","article-title":"The role of positron emission tomography\/computed tomography in the diagnosis of pleural diseases","volume":"57","author":"Orki","year":"2009","journal-title":"Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.010_bib0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MNM.0000000000000402","article-title":"The potential value of volume-based quantitative PET parameters and increased bone marrow uptake for the prediction of survival in patients with malignant pleural mesothelioma","volume":"37","author":"Ozmen","year":"2016","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.010_bib0019","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/MNM.0000000000001375","article-title":"Is 18F-FDG PET\/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma?","volume":"42","author":"\u00d6zmen","year":"2021","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.010_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cllc.2019.08.003","article-title":"Development of a novel prognostic risk classification system for malignant pleural mesothelioma","volume":"21","author":"Doi","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1053\/j.semnuclmed.2026.05.010_bib0021","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejrad.2016.11.019","article-title":"Prognostic value of pretreatment volume-based quantitative (18)F-FDG PET\/CT parameters in patients with malignant pleural mesothelioma","volume":"86","author":"Kitajima","year":"2017","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.05.010_bib0022","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.18632\/oncotarget.27979","article-title":"Deep learning with deep convolutional neural network using FDG-PET\/CT for malignant pleural mesothelioma diagnosis","volume":"12","author":"Kitajima","year":"2021","journal-title":"Oncotarget"},{"issue":"1086","key":"10.1053\/j.semnuclmed.2026.05.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170814","article-title":"(18)F-FDG PET\/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center","volume":"91","author":"Elliott","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2026.05.010_bib0024","first-page":"48","article-title":"Value of contrast CT in combination with PET\/CT in mesothelioma staging: optimal protocol for initial assessment","author":"Houseni","year":"2016","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2214\/AJR.18.20111","article-title":"Whole-body MRI: comparison of its capability for TNM staging of malignant pleural mesothelioma with that of coregistered PET\/MRI, integrated FDG PET\/CT, and conventional imaging","volume":"212","author":"Ohno","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.010_bib0026","first-page":"239","article-title":"Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma","volume":"46","author":"Kr\u00fcger","year":"2007","journal-title":"Nuklearmedizin"},{"issue":"1-2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0027","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2152\/jmi.56.16","article-title":"Is FDG-PET\/CT useful for managing malignant pleural mesothelioma?","volume":"56","author":"Otsuka","year":"2009","journal-title":"J Med Invest"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.05.010_bib0028","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/RLI.0b013e3181817b3d","article-title":"Computed tomography, positron emission tomography, positron emission tomography\/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results","volume":"43","author":"Plathow","year":"2008","journal-title":"Invest Radiol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.010_bib0029","first-page":"168","article-title":"The role of 18f-Fdg pet-Ct in diagnosis and prediction of prognosis in malignant pleural Mesothelioma","volume":"82","author":"Has Simsek","year":"2019","journal-title":"J Istanb Fac Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.010_bib0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3816\/CLC.2009.n.033","article-title":"Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma","volume":"10","author":"Wilcox","year":"2009","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MNM.0000000000000789","article-title":"18F-Fluorodeoxyglucose PET\/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma","volume":"39","author":"Hall","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229299","article-title":"Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET\/CT scan in patients with malignant pleural mesothelioma","volume":"15","author":"Lim","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.010_bib0033","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000381922","article-title":"Positron emission tomography\/computed tomography for the pleural staging of malignant pleural mesothelioma: how accurate is it?","volume":"89","author":"Pinelli","year":"2015","journal-title":"Respiration"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.010_bib0034","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5606\/tgkdc.dergisi.2021.20432","article-title":"The prognostic value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography parameters in patients with malignant pleural mesothelioma","volume":"29","author":"Yenig\u00fcn","year":"2021","journal-title":"Turk Gogus Kalp Damar Cerrahisi Derg"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0035","first-page":"333","article-title":"Clinical implications of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma","volume":"27","author":"Abe","year":"2012","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.010_bib0036","first-page":"187","article-title":"The role of FDG PET-CT in differential diagnosis of pleural pathologies","volume":"31","author":"Elboga","year":"2012","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.010_bib0037","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ejca.2012.01.016","article-title":"Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma","volume":"48","author":"Kaira","year":"2012","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.010_bib0038","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11604-010-0449-6","article-title":"Preliminary study of positron emission tomography\/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease","volume":"28","author":"Kurata","year":"2010","journal-title":"Jpn J Radiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.010_bib0039","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1754-9485.13592","article-title":"The prognostic value of F18 fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy - a prospective cohort study","volume":"68","author":"May","year":"2024","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00259-013-2561-1","article-title":"The association of 18F-FDG PET\/CT parameters with survival in malignant pleural mesothelioma","volume":"41","author":"Klabatsa","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.05.010_bib0041","doi-asserted-by":"crossref","unstructured":"T\u00fcz\u00fcn, F., et al., Effects of the changes between pre- and post-treatment 18F-FDG PET-CT volumetric parameters on overall survival in pleural mesothelioma. 2023.","DOI":"10.5603\/OCP.2023.0022"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.05.010_bib0042","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/JTO.0b013e3181c0a7ff","article-title":"Clinical value of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study","volume":"4","author":"Yildirim","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.010_bib0043","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.2967\/jnumed.124.267473","article-title":"Fibroblast activation protein-directed imaging outperforms (18)F-FDG PET\/CT in malignant mesothelioma: a prospective, single-center, observational trial","volume":"65","author":"Kessler","year":"2024","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.010_bib0044","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5114\/aoms\/111529","article-title":"How can we use positron emission tomography\/computed tomography more accurately for characterization of asbestos-related pleural thickening?","volume":"19","author":"Simsek","year":"2023","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.010_bib0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40291-024-00756-4","article-title":"Emerging radiopharmaceuticals in pet imaging for mesothelioma: a review of [(18)F]FDG alternatives","volume":"29","author":"Guglielmo","year":"2025","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.010_bib0046","first-page":"191","article-title":"(18)F-FDG PET\/CT in therapy response and in predicting responders or non-responders in malignant pleural mesothelioma patients, by using semi-quantitative mRECIST and EORTC criteria","volume":"21","author":"Niccoli Asabella","year":"2018","journal-title":"Hell J Nucl Med"},{"issue":"39","key":"10.1053\/j.semnuclmed.2026.05.010_bib0047","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030711","article-title":"Factors affecting the life expectancy in malignant pleural mesothelioma: our 10 years of studies and experience","volume":"101","author":"Cimen","year":"2022","journal-title":"Med (Baltim)"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.05.010_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13092600","article-title":"Diagnostic accuracy of ultrasound guided percutaneous pleural needle biopsy for malignant pleural mesothelioma","volume":"13","author":"Iadevaia","year":"2024","journal-title":"J Clin Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.05.010_bib0049","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-010-1107-z","article-title":"Volume-based parameter of 18)F-FDG PET\/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications","volume":"17","author":"Lee","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.05.010_bib0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/MNM.0000000000001078","article-title":"In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma","volume":"40","author":"Lopci","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.010_bib0051","first-page":"11","article-title":"Feasibility and performance of an adaptive contrast-oriented FDG PET\/CT quantification technique for global disease assessment of malignant pleural mesothelioma and a brief review of the literature","volume":"18","author":"Marin-Oyaga","year":"2015","journal-title":"Hell J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.05.010_bib0052","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2967\/jnumed.119.238733","article-title":"(18)F-FDG PET assessment of malignant pleural mesothelioma: total lesion volume and total lesion glycolysis-the Central role of volume","volume":"61","author":"Reynolds","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.05.010_bib0053","doi-asserted-by":"crossref","unstructured":"S\u00f6yler, Y., et al., The efficacy of (18)F-FDG PET\/CT in monitoring disease progression in malignant pleural mesothelioma. Upstream connect error or disconnect\/reset before headers reset reason: connection termination, 2023. 42(1): p. 3\u20139.","DOI":"10.1016\/j.remnie.2022.09.005"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.010_bib0054","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2009.04.015","article-title":"Combined FDG-PET\/CT in response evaluation of malignant pleural mesothelioma","volume":"67","author":"Veit-Haibach","year":"2010","journal-title":"Lung Cancer"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:55:07Z","timestamp":1794430507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0001299826001212"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.010","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic performance and clinical value of [18F]FDG PET\/CT in pleural mesothelioma \u2013 A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}